RPAM
ABMD
Rhenman & Partners Asset Management’s Abiomed Inc ABMD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-85,900
| Closed | -$21.7M | – | 96 |
|
2022
Q3 | $21.7M | Buy |
85,900
+12,900
| +18% | +$3.25M | 2.27% | 12 |
|
2022
Q2 | $18.1M | Buy |
73,000
+5,000
| +7% | +$1.24M | 2.05% | 17 |
|
2022
Q1 | $22.5M | Buy |
68,000
+16,000
| +31% | +$5.3M | 2.22% | 13 |
|
2021
Q4 | $18.8M | Sell |
52,000
-18,000
| -26% | -$6.52M | 1.25% | 32 |
|
2021
Q3 | $22.8M | Buy |
70,000
+5,000
| +8% | +$1.63M | 1.6% | 21 |
|
2021
Q2 | $20.3M | Sell |
65,000
-13,000
| -17% | -$4.06M | 1.38% | 30 |
|
2021
Q1 | $24.9M | Buy |
78,000
+15,000
| +24% | +$4.78M | 1.73% | 20 |
|
2020
Q4 | $20.4M | Sell |
63,000
-7,000
| -10% | -$2.27M | 1.67% | 23 |
|
2020
Q3 | $19.4M | Buy |
70,000
+2,000
| +3% | +$554K | 1.72% | 21 |
|
2020
Q2 | $16.4M | Sell |
68,000
-20,000
| -23% | -$4.83M | 1.77% | 19 |
|
2020
Q1 | $12.8M | Buy |
88,000
+1,000
| +1% | +$145K | 1.79% | 18 |
|
2019
Q4 | $14.8M | Sell |
87,000
-33,000
| -28% | -$5.63M | 1.63% | 22 |
|
2019
Q3 | $21.3M | Buy |
120,000
+27,100
| +29% | +$4.82M | 2.68% | 7 |
|
2019
Q2 | $24.2M | Buy |
92,900
+407
| +0.4% | +$106K | 2.67% | 9 |
|
2019
Q1 | $26.4M | Buy |
92,493
+27,183
| +42% | +$7.76M | 3.09% | 4 |
|
2018
Q4 | $21.2M | Buy |
65,310
+9,609
| +17% | +$3.12M | 2.43% | 9 |
|
2018
Q3 | $25.1M | Sell |
55,701
-4,699
| -8% | -$2.11M | 2.51% | 7 |
|
2018
Q2 | $24.7M | Sell |
60,400
-16,090
| -21% | -$6.58M | 2.53% | 5 |
|
2018
Q1 | $22.3M | Sell |
76,490
-10,000
| -12% | -$2.91M | 2.74% | 6 |
|
2017
Q4 | $16.2M | Sell |
86,490
-53,748
| -38% | -$10.1M | 2.19% | 14 |
|
2017
Q3 | $23.6M | Buy |
140,238
+34,088
| +32% | +$5.75M | 3.02% | 4 |
|
2017
Q2 | $15.2M | Sell |
106,150
-10,898
| -9% | -$1.56M | 2.18% | 13 |
|
2017
Q1 | $14.7M | Buy |
117,048
+14,348
| +14% | +$1.8M | 2.32% | 7 |
|
2016
Q4 | $11.6M | Buy |
102,700
+17,700
| +21% | +$1.99M | 2.22% | 10 |
|
2016
Q3 | $10.9M | Sell |
85,000
-20,000
| -19% | -$2.57M | 1.74% | 20 |
|
2016
Q2 | $11.5M | Sell |
105,000
-20,000
| -16% | -$2.19M | 2.04% | 14 |
|
2016
Q1 | $11.9M | Sell |
125,000
-95,000
| -43% | -$9.01M | 2.35% | 9 |
|
2015
Q4 | $19.9M | Buy |
220,000
+144,000
| +189% | +$13M | 3% | 2 |
|
2015
Q3 | $7.05M | Sell |
76,000
-28,000
| -27% | -$2.6M | 1.12% | 37 |
|
2015
Q2 | $6.84M | Buy |
104,000
+49,000
| +89% | +$3.22M | 0.82% | 38 |
|
2015
Q1 | $3.94M | Sell |
55,000
-18,000
| -25% | -$1.29M | 0.66% | 51 |
|
2014
Q4 | $2.78M | Sell |
73,000
-47,736
| -40% | -$1.82M | 0.81% | 49 |
|
2014
Q3 | $3M | Buy |
120,736
+13,736
| +13% | +$341K | 0.88% | 40 |
|
2014
Q2 | $2.69M | Buy |
107,000
+17,084
| +19% | +$429K | 0.8% | 46 |
|
2014
Q1 | $2.34M | Buy |
89,916
+24,916
| +38% | +$649K | 0.7% | 51 |
|
2013
Q4 | $1.74M | Buy |
+65,000
| New | +$1.74M | 0.68% | 64 |
|